| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1177172A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
| 02/06/2002 | EP1176959A1 Novel prolines as antimicrobial agents |
| 02/06/2002 | EP1176958A1 Novel catechols as antimicrobial agents |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP0836605B1 Pyrrolopyrimidines and processes for the preparation thereof |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | EP0659082B1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334730A Vitronectin receptor antagonist |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/01/2002 | CA2354275A1 Process for preparing basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008226A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics |
| 01/31/2002 | WO2002007730A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | WO2001081347A3 Diazabicyclic central nervous system active agents |
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | US20020013467 Antiallergens; antiinflammatory agents |
| 01/31/2002 | US20020013460 Condensed pyridine compound |
| 01/31/2002 | US20020013354 p38 map kinase inhibitors |
| 01/31/2002 | US20020013352 Novel substituted diamine derivatives useful as motilin antagonists |
| 01/31/2002 | US20020013334 HMG-CoA reductase inhibitors and method |
| 01/31/2002 | US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers |
| 01/31/2002 | US20020013332 Use of nicergoline for treating spasticity |
| 01/31/2002 | US20020013329 For therapy of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in therapy of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain |
| 01/31/2002 | US20020013328 For therapy of cancer or other proliferative diseases |
| 01/31/2002 | US20020013325 Useful as glycoprotein IIb/IIIa antagonists for prophylaxis thrombosis, therapy of atheroschlerosis, arterioschlerosis, acute myocardial infarction, chronic stable angina, unstable angina, transient ischemic attacks and strokes |
| 01/31/2002 | US20020013322 Novel compounds for enhancing chemotherapy |
| 01/31/2002 | US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester |
| 01/31/2002 | US20020013309 Pharmaceutical compositions and methods for use |
| 01/31/2002 | DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide |
| 01/31/2002 | CA2418194A1 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | CA2416751A1 Alpha v integrin receptor antagonists |
| 01/30/2002 | EP1176141A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR |
| 01/30/2002 | EP1175420A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP0937044B1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 01/30/2002 | EP0891187B1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | CN1333776A Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 01/30/2002 | CN1333773A Process for preparing N6-substituted deaza-adenosine derivatives |
| 01/30/2002 | CN1333772A Imidazo (4,5-c)-pyridine-4-on-derivatives |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333757A Quinazoline derivatives as medicaments |
| 01/30/2002 | CN1333685A Utilisation of I compound for the prophylaxis and therapy of cerebral ischaemia |
| 01/30/2002 | CN1332962A Process for prepairng weedicide imidazolinone compound |
| 01/29/2002 | US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/28/2002 | CA2704691A1 Indole derivatives and their use as medicaments |
| 01/24/2002 | WO2002006282A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides |
| 01/24/2002 | WO2002006240A1 Substituted 4,9-dihydrocyclopenta[imn] phenanthridine-5-ones, derivatives thereof and their uses |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001053268B1 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001029037A3 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 01/24/2002 | WO2001029000A3 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | WO2001023385A3 Novel tropane analogs |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | US20020010370 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same |
| 01/24/2002 | US20020010207 Tropane analogs and methods for inhibition of monoamine transport |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010189 For treatment of sexual disorders, male erectile dysfunction |
| 01/24/2002 | US20020010183 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 01/24/2002 | US20020010176 Integrin receptor antagonists |
| 01/24/2002 | US20020010171 New compounds, their preparation and use |
| 01/24/2002 | US20020010159 Proton pump inhibitors |
| 01/24/2002 | US20020010098 Insecticides, nematodicides |
| 01/24/2002 | DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis |
| 01/24/2002 | CA2416384A1 Sulfone derivatives, their production and use |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/23/2002 | EP1173520A1 Novel amidopyrylium fluorescence dyes |
| 01/23/2002 | EP1173519A1 Novel carbopyronine fluorescence dyes |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173439A1 Haloalkoxy imidazonaphthyridines |
| 01/23/2002 | EP1173438A1 Substituted imidazoles, their preparation and use |
| 01/23/2002 | EP1173181A2 Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction |
| 01/23/2002 | EP1173180A1 Camptothecin analogs and methods of preparation thereof |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173167A1 Treatment of female arousal disorder |
| 01/23/2002 | EP1025100B1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332743A Cell adhesion-inhibiting antinflammatory compounds |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332726A Pyrrolidine compounds and medicinal utilizaion thereof |
| 01/23/2002 | CN1332628A Method of treating sexual disturbances |
| 01/22/2002 | US6340759 Fused pyridine derivatives |
| 01/22/2002 | US6340744 Spectrofluorimetrically detection macrocyclic complex |
| 01/22/2002 | US6340690 Inhibiting hepatitis or herpes viral infections |
| 01/22/2002 | US6340682 Diamide compound and drugs containing the same |